Total submissions: 3
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Blueprint Genetics | RCV001073352 | SCV001238892 | uncertain significance | Retinal dystrophy | 2018-12-21 | criteria provided, single submitter | clinical testing | |
Labcorp Genetics |
RCV001220401 | SCV001392389 | uncertain significance | not provided | 2022-10-18 | criteria provided, single submitter | clinical testing | This sequence change replaces tyrosine, which is neutral and polar, with cysteine, which is neutral and slightly polar, at codon 1139 of the ABCA4 protein (p.Tyr1139Cys). This variant is present in population databases (rs150895509, gnomAD 0.1%). This missense change has been observed in individual(s) with ABCA4-related disease (PMID: 25066811). ClinVar contains an entry for this variant (Variation ID: 865830). Advanced modeling of protein sequence and biophysical properties (such as structural, functional, and spatial information, amino acid conservation, physicochemical variation, residue mobility, and thermodynamic stability) performed at Invitae indicates that this missense variant is not expected to disrupt ABCA4 protein function. In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. |
Fulgent Genetics, |
RCV002497485 | SCV002775272 | uncertain significance | Cone-rod dystrophy 3; Age related macular degeneration 2; Severe early-childhood-onset retinal dystrophy; Retinitis pigmentosa 19 | 2022-02-07 | criteria provided, single submitter | clinical testing |